SCHEMBL9039365

SCHEMBL9039365

CC(C)=CCn1ccc2cc(/C(C)=C/C(=O)O)ccc21

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9039391 1.00 — —
SCHEMBL9033792 0.83 PLG (0.44) —
SCHEMBL9033786 0.83 PLG (0.44) —
SCHEMBL9032942 0.82 HTR2A (0.41) —
SCHEMBL9032954 0.82 HTR2A (0.41) —
SCHEMBL9032672 0.82 NR4A1 (0.40) —
SCHEMBL9032659 0.82 NR4A1 (0.40) —
SCHEMBL9034120 0.81 PLG (0.48) —
SCHEMBL9032886 0.81 HDAC8 (0.52) —
SCHEMBL9032866 0.81 HDAC8 (0.52) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0511477-B1 Indole derivatives KYOWA HAKKO KOGYO KK (JP) 1996-07-10 — — EP disclosed
US-5239083-A Anticarcinogenic agents, prostate cancer treatment KYOWA HAKKO KOGYO CO., LTD. (JP) 1993-08-24 — — US disclosed
EP-0511477-A1 Indole derivatives KYOWA HAKKO KOGYO CO., LTD. (JP) 1992-11-04 — — EP disclosed
Send feedback